Health Care Private Equity



Private equity activity in the health care marketplace is strong and continues to build momentum. With a proven track record and real-time deal experience, we help our clients confidently navigate the dynamic health care regulatory landscape and business environment in order to effectively structure these transactions.

Our Approach

We understand the health care industry’s complex and ever-changing regulations that create unique challenges for private equity investments.

Our Health Care Private Equity team has served as both general and special counsel to private equity firms and other investors, guiding them through their initial acquisition of portfolio companies, add-on transactions and exit transactions.

We also have significant experience on the sell side of private equity transactions. Our team of transactional and health care regulatory lawyers work closely with lawyers throughout the firm who understand the range of issues applicable to health care clients, including tax, labor and employment, intellectual property, real estate and commercial and government regulation litigation.

We Work With

We have vast experience counseling clients in various sectors of the health care industry, including:

  • Behavioral health
  • Dental
  • Dermatology
  • Dialysis
  • Fertility
  • Infusion
  • Ophthalmology
  • Pharmacy
  • Physical therapy

We partner with our clients throughout:

  • Mergers and acquisitions
  • Recapitalizations
  • Stock and asset purchases
  • Regulatory compliance/analysis
  • Due diligence analyses
  • Business, legal and management issues affecting portfolio companies
  • Affiliations and joint ventures

Representative Experience

  • Private equity firm as health care regulatory counsel in multiple transactions, including the sale of its portfolio company and the purchase of a multi-state DSO, and continuing representation of the DSO on add-on acquisitions
  • Leading single-specialty anesthesia management company as general counsel in their reorganization with a private equity fund and expansion of their business
  • DSO (private equity firm client portfolio company), as regulatory counsel, in connection with its sale to a DSO; also assisted the private equity firm in its exit/merger of a DSO into another DSO
  • National provider of medical, cosmetic and dermatology services with 50+ locations in connection with its $100-million recapitalization by a private equity firm; ongoing representation in all health care regulatory matters
  • Leading middle-market private equity firm, as health care regulatory counsel, in connection with the acquisition of two multi-state providers of mobile dentistry services with combined acquisition price of approximately $80 million
  • National provider of physical, occupational and speech therapy services (owned by a physician-founded private equity firm) in connection with an affiliation with a large physicians practice across New York State
  • Large, multi-specialty physical therapy practice in its recapitalization by a private equity firm
  • Private equity firm in its recapitalization of an endodontics practice and affiliated practices; transaction included the formation of a DSO, which we continue to represent on add-on transactions
  • Private equity firm in its partnership with a leading thirteen-physician ophthalmology group (with its own ASC) in California
  • Private equity firm in its acquisition of a pediatric home care provider
  • Private equity owned, leading dental practice management company in connection with the acquisition of dental practices throughout New York, Massachusetts, New Jersey and Virginia
  • Private equity firm as regulatory counsel for the purchase of a physical therapy network with 50 locations throughout the Mid-Atlantic region
  • Independent, specialized pharmacy as health care regulatory counsel in connection with its private equity recapitalization
Back to top